Sinha S, Relhan V, Garg V
Indian J Dermatol. 2015; 60(2):118-29.
PMID: 25814698
PMC: 4372902.
DOI: 10.4103/0019-5154.152502.
Burkhart C, Burkhart C, Lehmann P
Postgrad Med J. 1999; 75(884):328-31.
PMID: 10435165
PMC: 1741272.
DOI: 10.1136/pgmj.75.884.328.
Mitcheson H, Sadler T, Castro J
Br J Cancer. 1980; 41(3):407-14.
PMID: 7387830
PMC: 2010249.
DOI: 10.1038/bjc.1980.64.
Buck G, Kelly M
Infect Immun. 1980; 27(2):620-7.
PMID: 7380542
PMC: 550809.
DOI: 10.1128/iai.27.2.620-627.1980.
ONEILL G, Stebbing N
Br J Cancer. 1980; 41(2):243-9.
PMID: 7370164
PMC: 2010188.
DOI: 10.1038/bjc.1980.36.
Mechanisms of C. Parvum-induced coagulopathy in mice.
Mitcheson H, Hilgard P, McCraw A, Castro J
Br J Cancer. 1980; 41(1):117-22.
PMID: 7362773
PMC: 2010159.
DOI: 10.1038/bjc.1980.13.
Effects of the Landschütz ascites carcinoma and ascitic fluid on macrophage activity in C. parvum-injected mice.
McIntosh L, Thomson A
Br J Cancer. 1981; 43(4):496-504.
PMID: 7236491
PMC: 2010619.
DOI: 10.1038/bjc.1981.72.
Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition.
Lee W, SHALITA A, Suntharalingam K, Fikrig S
Infect Immun. 1982; 35(1):71-8.
PMID: 7054130
PMC: 350997.
DOI: 10.1128/iai.35.1.71-78.1982.
Genetic control of Propionibacterium acnes-induced protection of mice against Babesia microti.
Wood P, Clark I
Infect Immun. 1982; 35(1):52-7.
PMID: 7054129
PMC: 350994.
DOI: 10.1128/iai.35.1.52-57.1982.
Effects of Propionibacterium acnes treatment on the course of Mycobacterium leprae infection in mice.
Krahenbuhl J, Humphres R, Henika P
Infect Immun. 1982; 37(1):183-8.
PMID: 7049949
PMC: 347509.
DOI: 10.1128/iai.37.1.183-188.1982.
Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers.
Sawyer R, Moon R, BENEKE E
Infect Immun. 1981; 32(2):945-50.
PMID: 7019084
PMC: 351533.
DOI: 10.1128/iai.32.2.945-950.1981.
Enhancement of natural resistance to influenza virus in lipopolysaccharide-responsive and -nonresponsive mice by Propionibacterium acnes.
Gangemi J, HIGHTOWER J, Jackson R, Maher M, Welsh M, Sigel M
Infect Immun. 1983; 39(2):726-35.
PMID: 6832817
PMC: 348010.
DOI: 10.1128/iai.39.2.726-735.1983.
Nonspecific resistance to infection expressed within the Peyer's patches of the small intestine.
MacDonald T, Bashore M, CARTER P
Infect Immun. 1982; 37(1):390-2.
PMID: 6809636
PMC: 347540.
DOI: 10.1128/iai.37.1.390-392.1982.
Inhibition of normal rat macrophage functions by soluble tumor products. Effect of systemic treatment with bacterial immunomodulators.
Iannello D, Bonina L, Delfino D, Berlinghieri M, Mastroeni P
Cancer Immunol Immunother. 1984; 17(1):38-41.
PMID: 6428737
PMC: 11039157.
DOI: 10.1007/BF00205495.
Effect of Corynebacterium granulosum immunopotentiation on the pathogenesis of herpes simplex virus type 2 in BALB/c mice.
Gabrielson D, KELLEHER J, Varani J
Infect Immun. 1980; 30(3):791-6.
PMID: 6262241
PMC: 551385.
DOI: 10.1128/iai.30.3.791-796.1980.
Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum.
Ghaffar A, Cullen R, Dunbar N, Woodruff M
Br J Cancer. 1974; 29(3):199-205.
PMID: 4830143
PMC: 2009103.
DOI: 10.1038/bjc.1974.59.
Vaccines and cell-mediated immunity.
Collins F
Bacteriol Rev. 1974; 38(4):371-402.
PMID: 4613342
PMC: 413869.
DOI: 10.1128/br.38.4.371-402.1974.
The influence of killed Propionibacterium granulosum on experimental infection with Escherichia coli.
Hof H, Pulverer G
Med Microbiol Immunol. 1987; 176(2):75-8.
PMID: 3553883
DOI: 10.1007/BF00200677.
Haematological changes and iron metabolism in rats after administration of Corynebacterium parvum.
Brozovic B, Sljivic V, Warr G
Br J Exp Pathol. 1975; 56(2):183-92.
PMID: 1203175
PMC: 2072739.
Modifications in the handling in vitro of 125I-labelled keyhole limpet haemocyanin by peritoneal macrophages from mice pretreated with the adjuvant Corynebacterium parvum.
Wiener E, Bandieri A
Immunology. 1975; 29(2):265-74.
PMID: 1158386
PMC: 1445948.
